DL-FLUOROCITRIC ACID BARIUM SALT
- Product Code: 126342
CAS:
100929-81-5
| Molecular Weight: | 345.43 g./mol | Molecular Formula: | C6H5BaFO7 |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00079306 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry, sealed |
Product Description:
DL-Fluorocitric acid barium salt is primarily utilized in biochemical research as a potent inhibitor of aconitase, an enzyme involved in the tricarboxylic acid (TCA) cycle. By inhibiting aconitase, it disrupts cellular energy production, making it a valuable tool for studying metabolic pathways and cellular respiration. It is also employed in experimental studies to investigate the effects of metabolic inhibition on cell function, particularly in cancer research, where altered metabolism is a key feature. Additionally, it serves as a reference compound in analytical chemistry for method development and validation in detecting fluorocitrate derivatives.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Off-white to Yellow Powder |
| CARBON | 13.5-17.5 |
| SOLUBILITY IN 1N HCL | 50 mg/ml, Clear to Slightly Hazy, Colorless to Faint Yellow |
| Infrared Spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.025 | 10-20 days | $443.53 |
+
-
|
DL-FLUOROCITRIC ACID BARIUM SALT
DL-Fluorocitric acid barium salt is primarily utilized in biochemical research as a potent inhibitor of aconitase, an enzyme involved in the tricarboxylic acid (TCA) cycle. By inhibiting aconitase, it disrupts cellular energy production, making it a valuable tool for studying metabolic pathways and cellular respiration. It is also employed in experimental studies to investigate the effects of metabolic inhibition on cell function, particularly in cancer research, where altered metabolism is a key feature. Additionally, it serves as a reference compound in analytical chemistry for method development and validation in detecting fluorocitrate derivatives.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :